Concepedia

H. TANIGUCHI

HT

Statistics

Publications

1

Citations

16

H-Index

1

Active since

2021

Affiliations

Sumitomo Dainippon Pharma (Japan)(Current)

H. TANIGUCHI is an author at Sumitomo Dainippon Pharma (Japan) specializing in toxicity management, cell death in cancer, and reactive oxygen species generation.

ORCID

Publications per year

2021–2021

1

Publications

1

Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancer

H. TANIGUCHI, Toshiki Masuishi, Akihito Kawazoe et al. · International Journal of Clinical Oncology · 2021 · 16 citations · Full text

Medicine, Oncology, Pharmacology +15

1–1 of 1